Please check your internet connection and try again.
# Isoxsuprine Hydrochloride
## Overview
Isoxsuprine hydrochloride is a peripheral vasodilator.
## Primary Indications
* Treatment of peripheral vascular disease (e.g., intermittent claudication, Raynaud's disease) to improve blood flow.
* Historically used to suppress premature labor, but this use is generally not recommended due to lack of efficacy and safety concerns.
## Adult Dosing
* **Peripheral Vascular Disease:** 10-20 mg orally three to four times daily.
* **Maximum Daily Dose:** 80 mg.
## Pediatric Dosing
* No established pediatric dosing. Use is generally not recommended in children.
## Dose Adjustments
* No specific dose adjustments are routinely recommended for hepatic or renal impairment, but caution is advised.
## Contraindications
* Hypersensitivity to isoxsuprine.
* Individuals with a recent arterial hemorrhage or where increased cardiac workload is undesirable (e.g., significant cardiovascular disease).
## Adverse Effects
* **Common:** Nausea, vomiting, dizziness, weakness, flushing, rash.
* **Serious:** Hypotension, tachycardia, gastrointestinal upset.
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects. Monitor blood pressure closely.
* **Other Vasodilators:** Additive hypotensive effects.
## Monitoring
* Monitor for signs of efficacy (improvement in peripheral circulation).
* Monitor for adverse effects, particularly hypotension and tachycardia.
* Monitor blood pressure.
## Clinical Pearls
* Onset of action is typically 30 minutes to 1 hour, with effects lasting 2-4 hours.
* Efficacy in peripheral vascular disease can vary, and it is often used as adjunctive therapy.
* Due to its vasodilatory effects, it can cause a drop in blood pressure, especially in elderly patients or those with pre-existing cardiovascular conditions.
***
**Disclaimer:** This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines for definitive patient management decisions. Dosing may vary based on individual patient factors and local protocols.
